1959
DOI: 10.1111/j.1532-5415.1959.tb00178.x
|View full text |Cite
|
Sign up to set email alerts
|

An Evaluation of Orphenadrine Hydrochloride (Disipal)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1961
1961
1973
1973

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 1 publication
(2 reference statements)
0
2
0
Order By: Relevance
“…Usually the minor side effects encountered were reduced or eliminated by appropriate reduction in dosage. In several instances patients reported a sense of well being, an effect previously reported for orphenardine [3][4][5] and of value in the treatment of pain.…”
mentioning
confidence: 59%
“…Usually the minor side effects encountered were reduced or eliminated by appropriate reduction in dosage. In several instances patients reported a sense of well being, an effect previously reported for orphenardine [3][4][5] and of value in the treatment of pain.…”
mentioning
confidence: 59%
“…Orphenadrine hydrochloride (Disipal) has been used in the treatment of Parkinson's syndrome (paralysis agitans) since 1955. (23) It soon became apparent that the agent effectively relieved muscle spasm in a wide variety of skeletal muscle and neurologic disorders. (24) In order to provide long-term relaxation of skeletal muscle spasm, the citrate salt of orphenadrine (Norflex) has been incorporated in a plasticized matrix.…”
Section: Skeletal Muscle Spasmmentioning
confidence: 99%